Charles River Laboratories International, Inc.

Investigation Alert CRL: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below

Johnson Fistel, LLP is investigating potential claims on behalf of Charles River Laboratories International, Inc. (NYSE: CRL) against certain of its officers and directors.

If you have continuously owned Charles River Laboratories International, submit your information below:

On February 22, 2023, Charles River disclosed they received a subpoena from the Justice Department related to an investigation into illegal importation of nonhuman primates. The company said it intends to “fully cooperate” with the investigators, and will stop receiving nonhuman primates from Cambodia, for an undetermined time. It was also stated that, “there is currently no global source to replace the supply of nonhuman primates from Cambodia. So the current supply situation will result in study delays in the company’s safety assessment business, and have a negative impact on 2023 revenue and earnings.”

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. Johnson Fistel seeks to recover losses incurred due to violations of federal securities laws. For more information about the firm and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes.

Johnson Fistel, LLP
Jim Baker, Lead Securities Analyst
Telephone: (619) 814-4471